1Grundy SM,Brewer JrHB,Cleeman JI,et al.Definition of metabolic syndrome:report of the National Heart,Lung,and Blood Institute/American Heart Association conference on scientific issues related to definition[J].Circulation,2004,109(3):433-438.
4Mai C,Wang B,Wen J,et al.Lipoprotein-associated phospholipase A and AGEs are associated with cardiovascular risk factors in women with history of gestational diabetes mellitus[J].Gynecol Endocrinol,2014,30(3):241-244.
5Mayer O Jr,SeidlerováJ,Filipovsk J,et al.Unexpected inverse relationship between impaired glucose metabolism and lipoprotein-associated phospholipase A2 activity in patients with stable vascular disease[J].Eur J Intern Med,2014,25(6):556-560.
4Kolodgie FD, Burke AP, Skorija KS, et al. Lipoprotein-associ- ated phospholipaseA2 protein expression in the natural progres- sion of human coronary atherosclerosis [J]. Arterioscler Thromb Vasc Biol, 2006, 26 (11): 2523-2529.
5Jang Y, Kin OY, Koh SJ, et al. The Val279Phe variant of the lipoprotein-associated phospholipaseA2 gene is associated with catalytic activities and cardiovascular disease in Korean men [J]. J Clin Endocrinol Metab, 2006, 91 (9): 3521 -3527.
6Koenig W, Twardella D, Brenner H, et al. Lipoprotein -asso- ciated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflaramation, renal function, and he modynamic stress [J]. Arterioscler Thromb Vasc Biol, 2006, 26 (7): 1586-1593.
7Sutton BS, Crosslin DR, Shah SH, et al. Comprehensive genetic a- nalysis of the platelet activating factor acetylhydrolase (PLA2GT) gene and cardiovascular disease in case-control and family datasets [J]. Hum Mol Genet, 2008,17(9) : 1318- 1328.
8Hou L, Chen, S, Yu H, et al. Associations of PLA2G7 gene polymorphisms with plasma lipoprotein- associated phospho- lipase A2 activity and coronary heart disease in a Chinese Han population: the Beijing atherosclerosis study [J]. Hum Genet, 2009, 125 (1): 11-20.
9Ninio E, Tregouet D, Carrier JL, et al. PAF-AH and PAF- receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease [J]. Hum Mol Genet, 2004, 13 (13): 1341-1351.
10Liu PY, Chung HC, Chen JY, et al. Platelet-activating factor -acetylhydrolase (PLA2GT) A379V (Exon 11) gene polymor- phism is functionally associated with coronary artery disease se- verity but not onset of acute coronary syndrome [J]. Acta Car- diolSin, 2006, 22: 212-220.
1Hok-Hay S. Oei,Irene M. van der Meer,Albert Hofman,Peter J. Koudstaal,Theo Stijnen,Monique M.B. Breteler,Jacqueline C.M. Witteman.Lipoprotein-Associated Phospholipase A2 Activity Is Associated With Risk of Coronary Heart Disease and Ischemic Stroke: The Rotterdam Study[J]. Circulation . 2005 (5)
2Koenig Wolfgang,Twardella Dorothee,Brenner Hermann,Rothenbacher Dietrich.Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress. Arteriosclerosis . 2006
3Jones Gregory T,Deng Meiying,Hammond-Tooke Graeme D,McCormick Sally P A,van Rij Andre M.Increased plasma lipoprotein(a) found in large-artery atherosclerotic, but not small-artery occlusive, stroke. Clinical Chemistry . 2009
4Ait-Oufella H,Mallat Z,Tedgui A.Lp-PLA2 and s PLA2:cardiovascular biomarkers. Med Sci (Paris) . 2014
5Petersen NH,Schmied AB,Zeller JA,etal.LP(a) lLipoprotein and Plasminogen Activity in patients with different Etiology of Ischemic Stroke. Cerebrovascular Diseases . 2007
6Oana Vittos,Bogdan Toana,Alexandros Vittos,Elena Moldoveanu.??Lipoprotein-associated phospholipase A2 (Lp-PLA2): a review of its role and significance as a cardiovascular biomarker(J)Biomarkers . 2012 (4)
7Marie-Germaine Bousser,Isabelle Crassard.??Cerebral venous thrombosis, pregnancy and oral contraceptives(J)Thrombosis Research . 2012
